Medically Reviewed Content
Written by Rob Anderson, Health Technology Researcher & Medical Content Specialist. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting any medication.
Questions about semaglutide and fertility are increasingly common — especially among women in their reproductive years using GLP-1 medications for weight management. Here is what the evidence shows.
Does Semaglutide Cause Infertility?
No evidence shows semaglutide causes infertility in men or women. It does not affect ovarian reserve, sperm quality, or the fundamental mechanisms of reproduction. Some women actually find improved fertility outcomes on semaglutide — particularly those with PCOS, where insulin resistance and elevated androgens suppress ovulation.
Ozempic and PCOS Fertility
Women with PCOS often have irregular or absent periods due to the hormonal disruption of insulin resistance and elevated androgens. Semaglutide addresses these root causes — improving insulin sensitivity, reducing weight, and lowering androgen levels — which can restore menstrual regularity and ovulation for some women. This is an actively studied area and an important reason some physicians prescribe semaglutide off-label specifically for PCOS management.
The Critical Warning: Pregnancy Safety
Semaglutide is not safe during pregnancy. Animal studies showed fetal harm at exposures comparable to human therapeutic doses, including reduced fetal body weight and skeletal abnormalities. The drug is currently classified as Pregnancy Category D equivalent — meaning potential fetal risk. This is not a theoretical concern: it is a real one that requires active management.
Recommended protocol: Stop semaglutide at least 2 months before trying to conceive (the half-life is approximately one week, so 2 months provides adequate clearance). Use effective contraception throughout treatment. If pregnancy occurs unexpectedly while on semaglutide, stop the medication immediately and contact your obstetrician.
Improving Fertility Through Weight Loss
For women who are overweight and struggling with fertility, the weight loss achieved through semaglutide can independently improve fertility — even before considering drug-specific effects. A 5–10% reduction in body weight can significantly improve ovulatory function, IVF outcomes, and pregnancy rates in overweight women with fertility challenges. Some fertility clinics now recommend semaglutide prior to IVF cycles for this reason (stopping well before embryo transfer).
For Men: Minimal Evidence of Concern
Limited data exists on semaglutide and male fertility specifically. No clinical evidence shows impaired sperm quality or testosterone levels in men using semaglutide. The general principle applies: significant weight loss may actually improve testosterone levels and sexual function in overweight men by reducing oestrogen conversion from fat tissue.
Frequently Asked Questions
Q: Does Ozempic affect fertility?
A: Semaglutide is not known to directly impair fertility. In women with PCOS (polycystic ovary syndrome), it may actually improve fertility by restoring menstrual regularity through improved insulin sensitivity and weight loss. However, semaglutide must be stopped before trying to conceive and is not safe during pregnancy.
Q: Can you get pregnant while on Ozempic?
A: You can become pregnant while on Ozempic — the drug does not prevent ovulation or act as contraception. Women on semaglutide who could become pregnant should use effective contraception. Semaglutide should be stopped at least 2 months before planned conception.
Q: What happens if you take Ozempic while pregnant?
A: Animal studies showed fetal harm at doses producing exposures comparable to human therapeutic doses. Semaglutide is not recommended during pregnancy. If pregnancy occurs while on semaglutide, it should be stopped immediately and your obstetrician informed.
📖 Further Reading
Speak With a Physician About Your Eligibility
Physician-supervised compounded semaglutide from $149/month. No insurance required.
Sponsored | Affiliate link
Planning Your Timeline: Transitioning Off Semaglutide Before Conception
If you are considering pregnancy while using Ozempic, developing a clear transition plan with your healthcare provider is essential. Most guidelines recommend discontinuing semaglutide at least two months before attempting to conceive, allowing the medication to fully clear your system. During this transition period, focus on maintaining your weight loss through sustainable habits including a nutrient-dense diet and regular physical activity. Work with your doctor to establish a prenatal vitamin regimen that includes folic acid, iron, and DHA. Patients with PCOS may find that the weight loss achieved through semaglutide therapy has already improved their hormonal balance and ovulation patterns, making conception easier even after stopping the medication.
Affiliate disclosure: This article contains affiliate links. See our Affiliate Disclosure.
Sources & References
- U.S. Food and Drug Administration (FDA) – Drug Approvals and Databases
- National Institutes of Health (NIH) – PubMed Medical Literature
- American Diabetes Association – Medication & Therapies
- Novo Nordisk – Clinical Research Data
- Eli Lilly – Medical Information
This content is regularly reviewed and updated to reflect the latest medical research and FDA guidance.